FDA Deception on Abortion Drugs Puts Women at Risk

It’s always interesting when something that shouldn’t be all that interesting suddenly becomes extremely interesting to people who are not easily interested.

Recently, the academic publisher Sage retracted three studies from one of its journals. Ordinarily, retractions like these would not be newsworthy outside of the scholastic community, but in this case, some media outlets jumped at the chance to cover them. Why?

EH

About the Author

Erin Hawley

Erin Hawley is senior counsel and vice president of the Center for Life and Regulatory Practice at Alliance Defending Freedom (@ADFLegal).

Featured Tags

Manage following

Abortion

FDA

It’s always interesting when something that shouldn’t be all that interesting suddenly becomes extremely interesting to people who are not easily interested.

Recently, the academic publisher Sage retracted three studies from one of its journals. Ordinarily, retractions like these would not be newsworthy outside of the scholastic community, but in this case, some media outlets jumped at the chance to cover them. Why?